CLOV stock icon

Clover Health Investments

3.36 USD
+0.01
0.30%
At close Nov 21, 4:00 PM EST
Pre-market
3.36
+0.00
0.00%
1 day
0.30%
5 days
12.00%
1 month
-17.24%
3 months
-4.00%
6 months
262.38%
Year to date
250.07%
1 year
242.33%
5 years
-78.87%
10 years
-78.87%
 

About: Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. Operating in two segments, Insurance and Non-Insurance, Clover Health offers PPO and HMO plans to Medicare Advantage members in multiple states through its Insurance segment. In the Non-Insurance segment, the company participates in the ACO REACH Model. The majority of revenue is generated from the insurance segment, reflecting the significance of its healthcare insurance offerings.

Employees: 552

0
Funds holding %
of 6,754 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

153% more capital invested

Capital invested by funds: $91.5M [Q2] → $231M (+$140M) [Q3]

129% more first-time investments, than exits

New positions opened: 55 | Existing positions closed: 24

98% more call options, than puts

Call options by funds: $12.9M | Put options by funds: $6.51M

25% more funds holding

Funds holding: 124 [Q2] → 155 (+31) [Q3]

1.82% more ownership

Funds ownership: 18.29% [Q2] → 20.11% (+1.82%) [Q3]

3% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 33

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$4
19%
upside
Avg. target
$4
19%
upside
High target
$4
19%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
UBS
Jonathan Yong
0 / 0 met price target
19%upside
$4
Neutral
Initiated
7 Oct 2024

Financial journalist opinion

Based on 11 articles about CLOV published over the past 30 days

Charts implemented using Lightweight Charts™